Category: Mergers & Acquisitions
ConvaTec is reportedly weighing a sale of the private-equity-owned medical device company next year, even as interest in a Medtronic-like inversion deal mounts from C.R. Bard, CareFusion and 3M.
Medtech titans Medtronic and Covidien name more than 45 people to coordinate the finer points of their merger.
LeMaitre Vascular acquires another "under-marketed" device in Xenotis and its Omniflow II biological graft.
LeMaitre Vascular (NSDQ:LMAT) got a Wall Street boost today after reporting that it acquired graft-maker Xenotis is a deal valued at $7.7 million.
Allergan CFO Jeff Edwards is stepping down amid a $44 billion hostile takeover bid from Valeant Pharmaceuticals and Pershing Square Capital Management.
Allergan (NYSE:AGN) said today that longtime CFO Jeff Edwards is stepping down to honor a commitment he made to his family earlier this year, replaced by treasurer Jim Hindman effective immediately.
, Biolase Technology Inc.
, Insulet Corp.
, Monarch Medical
, Pershing Square Capital Management
, Trinity Medical
, Valeant Pharmaceuticals
, Volpara Solutions
, Allergan Inc.
Medtronic CEO Omar Ishrak seeks to reassure employees amid the political fallout over the tax inversion aspects of its $43 billion deal to acquire Covidien.
Bearish options trades on Covidien are driven by speculation that Medtronic will follow Walgreen in abandoning plans for a so-called tax inversion deal, Bloomberg reports.
Earl Bakken, the founder of Medtronic, tells employees he's behind the company's $43 billion acquisition of Covidien and its potential to save a life every second.